[1]
|
Schlesinger, N. (2011) Difficult-to-Treat Gouty Arthritis. Drugs, 71, 1413-1439. https://doi.org/10.2165/11592290-000000000-00000
|
[2]
|
Mbuyi, N. and Hood, C. (2020) An Update on Gout Diagnosis and Management for the Primary Care Provider. The Nurse Practitioner, 45, 16-25. https://doi.org/10.1097/01.npr.0000696896.83494.fe
|
[3]
|
Serafini, T.A. and Emerling, D.E. (2010) Tranilast Suppresses Inflammation Induced by Monosodium Urate (MSU) Crystals in Vivo. Annals of the Rheumatic Diseases, 69, 664.
|
[4]
|
Mandal, A.K., Mercado, A., Foster, A., Zandi-Nejad, K. and Mount, D.B. (2017) Uricosuric Targets of Tranilast. Pharmacology Research & Perspectives, 5, e00291. https://doi.org/10.1002/prp2.291
|
[5]
|
Heitel, P., Gellrich, L., Heering, J., Goebel, T., Kahnt, A., Proschak, E., et al. (2018) Urate Transporter Inhibitor Lesinurad Is a Selective Peroxisome Proliferator-Activated Receptor γ Modulator (sPPARγM) in Vitro. Scientific Reports, 8, Article No. 13554. https://doi.org/10.1038/s41598-018-31833-4
|
[6]
|
Mandal, A., Emerling, D., Serafini, T., et al. (2010) Tranilast Inhibits Urate Transport Mediated by URAT1 and GLUT9. Arthritis & Rheumatology, 62, 164.
|
[7]
|
Yu, C., Zhang, C., Kuang, Z. and Zheng, Q. (2020) The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification. Inflammation, 44, 434-449. https://doi.org/10.1007/s10753-020-01357-z
|
[8]
|
Tseng, H., Samuel, S.G., Schroder, K., Lévesque, J. and Alexander, K.A. (2022) Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease. Current Osteoporosis Reports, 20, 170-185. https://doi.org/10.1007/s11914-022-00729-8
|
[9]
|
唐秀松, 赵心怡, 陈静, 等. 基于细胞焦亡理论探讨中医药防治类风湿关节炎研究进展[J]. 中国实验方剂学杂 志, 2022, 28(19): 231-240.
|
[10]
|
Carneiro, L., Magalhaes, J., Tattoli, I., Philpott, D. and Travassos, L. (2007) Nod‐Like Proteins in Inflammation and Disease. The Journal of Pathology, 214, 136-148. https://doi.org/10.1002/path.2271
|
[11]
|
Ting, J.P., Lovering, R.C., Alnemri, E.S., Bertin, J., Boss, J.M., Davis, B.K., et al. (2008) The NLR Gene Family: A Standard Nomenclature. Immunity, 28, 285-287. https://doi.org/10.1016/j.immuni.2008.02.005
|
[12]
|
Davis, B.K., Wen, H. and Ting, J.P. (2011) The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases. Annual Review of Immunology, 29, 707-735. https://doi.org/10.1146/annurev-immunol-031210-101405
|
[13]
|
Jo, E., Kim, J.K., Shin, D. and Sasakawa, C. (2015) Molecular Mechanisms Regulating NLRP3 Inflammasome Activation. Cellular & Molecular Immunology, 13, 148-159. https://doi.org/10.1038/cmi.2015.95
|
[14]
|
Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., et al. (2009) Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression. The Journal of Immunology, 183, 787-791. https://doi.org/10.4049/jimmunol.0901363
|
[15]
|
Pu, Z.C., Han, C.Z., Zhang, W.W., et al. (2019) Systematic Understanding of the Mechanism and Effects of Arctigenin Attenuates Inflammation in Dextran Sulfate Sodium-Induced Acute Colitis through Suppression of NLPP3 Inflammasome by SIRT1. American Journal of Translational Research, 11, 3992-4009.
|
[16]
|
Wang, T., Wang, J., Sun, T. and Li, Y. (2021) Amelioration of Juglanin against LPS-Induced Activation of NLRP3 Inflammasome in Chondrocytes Mediated by Sirt1. Inflammation, 44, 1119-1129. https://doi.org/10.1007/s10753-020-01407-6
|
[17]
|
Mangan, M.S.J., Olhava, E.J., Roush, W.R., Seidel, H.M., Glick, G.D. and Latz, E. (2018) Erratum: Targeting the NLRP3 Inflammasome in Inflammatory Diseases. Nature Reviews Drug Discovery, 17, 688-688. https://doi.org/10.1038/nrd.2018.149
|
[18]
|
Zhang, Q., Qing, Y., He, Y., Xie, W. and Zhou, J. (2017) Association of NLRP3 Polymorphisms with Susceptibility to Primary Gouty Arthritis in a Chinese Han Population. Clinical Rheumatology, 37, 235-244. https://doi.org/10.1007/s10067-017-3900-6
|
[19]
|
Renaudin, F., Orliaguet, L., Castelli, F., Fenaille, F., Prignon, A., Alzaid, F., et al. (2020) Gout and Pseudo-Gout-Related Crystals Promote Glut1-Mediated Glycolysis That Governs NLRP3 and Interleukin-1β Activation on Macrophages. Annals of the Rheumatic Diseases, 79, 1506-1514. https://doi.org/10.1136/annrheumdis-2020-217342
|
[20]
|
Li, X., Liu, Y., Luo, C. and Tao, J. (2022) Z1456467176 Alleviates Gouty Arthritis by Allosterically Modulating P2X7R to Inhibit NLRP3 Inflammasome Activation. Frontiers in Pharmacology, 13, Article 979939. https://doi.org/10.3389/fphar.2022.979939
|
[21]
|
Reber, L.L., Marichal, T., Sokolove, J., Starkl, P., Gaudenzio, N., Iwakura, Y., et al. (2014) Contribution of Mast Cell-Derived Interleukin-1β to Uric Acid Crystal-Induced Acute Arthritis in Mice. Arthritis & Rheumatology, 66, 2881-2891. https://doi.org/10.1002/art.38747
|
[22]
|
刘丽兰, 关宝生, 张淑红, 等. 痛风炎症反应中NLRP3炎性体的激活机制[J]. 中医临床研究, 2022, 14(6): 128-130, 136.
|
[23]
|
Kong, R., Sun, L., Li, H. and Wang, D. (2021) The Role of NLRP3 Inflammasome in the Pathogenesis of Rheumatic Disease. Autoimmunity, 55, 1-7. https://doi.org/10.1080/08916934.2021.1995860
|
[24]
|
Wang, C.Y., Guo, X.C. and Zhang, J.P. (2015) Research Advances in NLRP3 Inflammasome-Related Regulatory Mechanisms. Acta Academiae Medicinae Sinicae, 37, 618-622.
|
[25]
|
Church, L.D., Cook, G.P. and McDermott, M.F. (2008) Primer: Inflammasomes and Interleukin 1β in Inflammatory Disorders. Nature Clinical Practice Rheumatology, 4, 34-42. https://doi.org/10.1038/ncprheum0681
|
[26]
|
李满意, 娄玉钤. 痛风的源流及历史文献复习[J]. 风湿病与关节炎, 2018, 7(6): 57-62.
|
[27]
|
王宏, 李娟, 杨小黎, 等. 基于“阳化气, 阴成形”理论探讨痛风的中医证治[J]. 四川中医, 2020, 38(6): 50-53.
|
[28]
|
刘海云, 于静, 姜兆荣, 等. 金明秀教授从“毒”论治痛风性关节炎经验总结[J]. 世界中西医结合杂志, 2018, 13(8): 1072-1074, 1078.
|
[29]
|
冯波, 陆定其, 胡文秀, 等. 王新昌运用温法治疗痛风经验介绍[J]. 新中医, 2020, 52(15): 198-200.
|
[30]
|
朴勇洙, 张京, 任慧, 等. 国医大师卢芳运用丹溪痛风方治疗痛风经验[J]. 浙江中医药大学学报, 2020, 44(8): 715-718.
|
[31]
|
国家中医药管理局发布中华人民共和国中医药行业标准——《中医病证诊断疗效标准》[J]. 中医药管理杂志, 1994(6): 2.
|
[32]
|
李壮, 侯堃. 316例男性急性痛风性关节炎中医证候分类研究[J]. 中医杂志, 2019, 60(1): 47-50.
|
[33]
|
唐兆安, 王莘智. 从肝论治痛风[J]. 中医研究, 2019, 32(5): 4-5.
|
[34]
|
张艳珍, 张红红, 王洁, 等. 1张艳珍分期论治痛风性关节炎的经验总结[J]. 中国当代医药, 2022, 29(29): 123-126.
|
[35]
|
王耀光, 赵景峰, 张诗元, 等. 王耀光教授治疗痛风性关节炎临床经验总结[J]. 天津中医药, 2022, 39(6): 706-709.
|
[36]
|
仇湘中, 沈琳玲, 戎宽, 等. 仇湘中教授治疗痛风性关节炎的经验总结[J]. 中国中医骨伤科杂志, 2022, 30(4): 79-81.
|
[37]
|
袁飞侠, 梅晴晴, 张华东, 等. 李济仁治疗痛风性关节炎经验总结与延展[J]. 北京中医药, 2021, 40(4): 334-337.
|
[38]
|
黄宝怡, 叶仁群, 梁奇参. 苓降酸煮散联合非布司他片治疗脾虚湿蕴型高尿酸血症临床疗效观察[J]. 广州中医药大学学报, 2022, 39(12): 2793-2798.
|
[39]
|
孙淳, 王秀娟, 刘华一, 等. 运脾化浊法治疗脾虚型高尿酸血症回顾性研究[J]. 安徽中医药大学学报, 2021, 40(1): 38-42.
|
[40]
|
徐熠, 徐玲玲, 刘静, 等. 中药治疗慢性痛风性关节炎的规律及其Logistic回归分析[J]. 世界临床药物, 2013, 34(8): 469-471.
|
[41]
|
佟金秋, 马宝东, 陈岩松. 痛风内治法用药规律系统综述[J]. 实用中医内科杂志, 2013, 27(10): 1-2.
|
[42]
|
那莎, 段陈方圆, 王璐, 等. 牛膝总皂苷对大鼠急性痛风性关节炎的防治作用及机制研究[J]. 中国临床药理学与治疗学, 2017, 22(9): 966-971.
|
[43]
|
孙雪莲, 刘渊, 周红海. 牛膝总皂苷对兔膝骨关节炎软骨组织形态变化及关节液中IL-1β、TGF-β1含量的影响[J]. 中药新药与临床药理. 2016, 27(3): 321-326.
|
[44]
|
马锐, 吴胜本. 中药黄酮类化合物药理作用及作用机制研究进展[J]. 中国药物警戒, 2013, 10(5): 286-290.
|
[45]
|
金晓敏, 张晓熙, 郭璐, 等. 基于NLRP3炎性体轴探讨土茯苓总黄酮对痛风性关节炎的作用和机制[J]. 中国实验方剂学杂志, 2018, 24(4): 90-95.
|
[46]
|
马天红, 盛涛, 田崇梅, 等 . 虎杖醇提物通过 NLRP3/ASC/caspase-1轴干预小鼠急性痛风性关节炎的作用研究[J]. 中国中药杂志, 2019, 44(3): 546-552.
|
[47]
|
元明慧, 姜禹辰, 廉丽花, 等. 白芷提取物及其活性成分欧前胡素改善痛风性关节炎[J]. 中国药理学通报, 2022, 38(9): 1416-1420.
|
[48]
|
范为民. 通痹七物方对痛风性关节炎NLRP3炎症小体、线粒体自噬蛋白的影响[J]. 中药新药与临床药理, 2020, 31(7): 769-774.
|
[49]
|
郭玉星, 熊辉, 易法银, 等. 蠲痹历节清方对痛风细胞模型中PPARγ、TLR4、NF-κB的影响[J]. 世界科学技术-中医药现代化, 2019, 21(12): 2825-2830.
|
[50]
|
康佳莹, 吴芸, 顾文燕. 加味黄芪桂枝五物汤对急性痛风性关节炎大鼠NLRP3、IL-33和TGF-β1表达的影响[J]. 中国中医急症, 2019, 28(11): 1989-1992.
|
[51]
|
张晓熙, 邢梦雨, 赵鑫钰, 等. 基于NLRP3炎性体轴和NF-κB信号通路探讨加味三妙丸防治痛风性关节炎的作用及机制[J]. 浙江中医药大学学报, 2019, 43(10): 1130-1137.
|
[52]
|
Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J., et al. (2020) 2018 Updated European League against Rheumatism Evidence-Based Recommendations for the Diagnosis of Gout. Annals of the Rheumatic Diseases, 79, 31-38. https://doi.org/10.1136/annrheumdis-2019-215315
|
[53]
|
张慧森, 刘健, 温石磊, 等. 温针灸治疗膝关节痛风性关节炎湿热蕴结证患者的疗效及对关节疼痛、关节功能和血清炎症指标的影响[J]. 河北中医, 2021, 43(7): 1170-1173.
|
[54]
|
肖艺, 周芬, 宋清, 等. 针刺联合中药外敷治疗急性痛风 性关节炎湿热痹阻证的疗效观察[J]. 上海针灸杂志, 2022, 41(1): 71-76.
|
[55]
|
位会娜, 曾丹怡, 尹诚语, 等. 电针干预急性痛风性关节炎小鼠NLRP3表达及镇痛作用研究[J]. 中国疼痛医学杂志, 2023, 29(4): 249-257.
|
[56]
|
谯童茜, 唐成林, 邱丽针, 等. 基于NLRP3炎性小体通路探讨电针对急性痛风性关节炎大鼠组织蛋白酶B的影响[J]. 针刺研究, 2021, 46(4): 295-300.
|
[57]
|
贺前松, 马萍, 陈瑶, 等. 微创针刀联合rHuEPO注射治疗痛风性关节炎的临床疗效及对TGF-1、NLRP3水平的影响[J]. 中国老年学杂志, 2019, 39(22): 5540-5544.
|